NYSE American · Medical Care Facilities · USD

Cryo-Cell International, Inc. (CCEL) Stock Analysis

Cryo-Cell International, Inc. (CCEL) is a Medical Care Facilities stock listed on NYSE American and quoted in US Dollar.

Last Updated: October 21, 2026

CCEL

$4.68

−$0.07 (−1.48%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CCEL with… →

CCEL Key Statistics

As of Oct 21, 2026

Trading

Open: $4.70
Previous Close: $4.75
Day's Range: 4.33–4.68
52-Week Range: 2.72–4.90
Volume: 12.15K
Beta: 0.59

Valuation

Market Cap: $34.67M
P/E Ratio: unprofitable
Forward P/E: 215.00
PEG Ratio: 1.34
P/S ratio: 1.11
EPS (ttm): −0.24

Financials (FY)

Revenue (FY): $31.57M−1.31%
Net Income (FY): −$2.43M−704.18%
Profit margin: −6.25%
Shares Outstanding: 8.06M
1-Year Return: +7.58%

Dividend and dates

Dividend: $0.60
Avg Volume: 24.68K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, CCEL closed at $4.68, +7.58% over 1 year.

Cryo-Cell International, Inc. (CCEL) has a market capitalization of $34.67M.

In fiscal 2025, CCEL reported revenue of $31.57M.

CCEL Stock Return by Calendar Year

Cryo-Cell International, Inc. (CCEL) 10-year return: what $10,000 became

1 year: $10,000 $10,758; +7.58%
5 years: $10,000 $4,620; −53.80%
10 years: $10,000 $14,230; +42.30%

If you had invested $10,000 in Cryo-Cell International, Inc. (CCEL) 10 years ago, at the close on October 21, 2016, it would have been worth $14,230 at the close on October 21, 2026: +42.30% in total, +3.59% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

+112.06%−58.46%+36.04%

2016*2017201820192020202120222023202420252026*

Year	Return
2026 (partial year)	+36.04%
2025	−50.64%
2024	+32.67%
2023	+35.93%
2022	−58.46%
2021	+50.65%
2020	+7.99%
2019	−4.93%
2018	−22.44%
2017	+112.06%
2016 (partial year)	+16.33%

As of October 21, 2026.

CCEL Revenue and Earnings by Fiscal Year

FY ends November

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$31.57M	−$2.43M	−7.7%
2024	$31.99M	$402.10K	1.3%
2023	$31.34M	−$9.52M	−30.4%
2022	$30.34M	$2.77M	9.1%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$31.57M	$24.19M	$4.84M	−$2.43M	−7.7%
2024	$31.99M	$24.04M	$3.79M	$402.10K	1.3%
2023	$31.34M	$22.95M	$3.49M	−$9.52M	−30.4%
2022	$30.34M	$21.54M	$4.46M	$2.77M	9.1%

Annual figures as reported, in the company's reporting currency. As of November 30, 2025.

CCEL Dividend History

’22’24’25

$0.40+60.0% vs 2024

Dividends per share, 2025 · 2 payments

Year	Dividends per share	Payments	Change
2025	$0.40	2	+60.0%
2024	$0.25	1	—
2022	$0.90	1	—

Most recent payment: $0.20 per share, ex-dividend May 21, 2025. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

CCEL Valuation vs Medical Care Facilities Median

Median of 54 stocks

Metric	CCEL	Medical Care Facilities median	vs median
P/S ratio	1.11	0.87	28% above
Profit margin	−6.25%	3.19%	9.4 pts below

Medians across 54 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Cryo-Cell International, Inc. (CCEL) carries a market capitalisation of $34.67M. It is classified in the Medical Care Facilities industry, within the Healthcare sector. The company reports 72 employees.

The 52-week range on file runs from $2.72 to $4.90. The most recent close on file for CCEL is $4.68, dated October 21, 2026. That is −$0.07 (−1.48%) against the previous close. The latest close sits 72.05% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $31.57M. That is −1.31% against the prior fiscal year, when revenue was $31.99M. The same year closed with a net loss of $2.43M. Profit margin runs at −6.25%. That is 9.4 percentage points below the Medical Care Facilities median of 3.19%. Trailing earnings per share are −0.24.

Across the 4 fiscal years on file, revenue moves from $30.34M in 2022 to $31.57M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. On forward earnings the ratio is 215. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.34. Measured against sales, the shares trade at 1.11 times revenue. On price-to-sales that is 28.19% above the Medical Care Facilities median of 0.87. The medians here are taken across 54 Medical Care Facilities companies that report the metric.

Beta against the wider market is reported at 0.59. Daily returns over the trailing 10 years annualize to a volatility of 59.23%. Over the trailing twelve months the total return is +7.58%. Across 10 years the annualized return works out at +3.59%.

Growth & Income

The latest dividend on file for CCEL dates from 2025. Dividends are recorded for 3 calendar years; 2025 shows 2 payments totalling $0.40 a share. The year before, 2024, totalled $0.25 a share.

So far in 2026 the total return is +36.04%. The strongest complete calendar year on file is 2017 at +112.06%; the weakest is 2022 at −58.46%. Of the 9 complete calendar years on file, 5 finished higher.

Peer Comparison

Cryo-Cell International, Inc. (CCEL) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Cryo-Cell International, Inc.	CCEL	$34.67M	—
HCA Healthcare, Inc.	HCA	$99.46B	15.4
Tenet Healthcare Corporation	THC	$21.67B	10.6
Encompass Health Corporation	EHC	$11.88B	20.2

The Medical Care Facilities industry average P/E ratio is 20.7x. Cryo-Cell International, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Care Facilities Stocks

HCA

HCA Healthcare, Inc.

$99.46B

THC

Tenet Healthcare Corporation

$21.67B

EHC

Encompass Health Corporation

$11.88B

FMS

Fresenius Medical Care AG

$11.47B

DVA

DaVita Inc.

$11.28B

UHS

Universal Health Services, Inc.

$10.78B

View all Medical Care Facilities stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

JNJ

Johnson & Johnson

$621.22B

ABBV

AbbVie Inc.

$503.27B

UNH

UnitedHealth Group Incorporated

$374.30B

MRK

Merck & Co., Inc.

$369.78B

View all Healthcare stocks →

About Cryo-Cell International, Inc.

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Visit website →